Literature DB >> 33030108

The Histopathology of Oral Cancer Pain in a Mouse Model and a Human Cohort.

K Naik1, M N Janal2, J Chen3, D Bandary3, B Brar3, S Zhang3, J C Dolan1, B L Schmidt1, D G Albertson1, A Bhattacharya1.   

Abstract

Oral cancer patients often have severe, chronic, and mechanically induced pain at the site of the primary cancer. Oral cancer pain is initiated and maintained in the cancer microenvironment and attributed to release of mediators that sensitize primary sensory nerves. This study was designed to investigate the histopathology associated with painful oral cancers in a preclinical model. The relationship of pain scores with pathologic variables was also investigated in a cohort of 72 oral cancer patients. Wild-type mice were exposed to the carcinogen, 4-nitroquinoline 1-oxide (4NQO). Nociceptive (pain) behavior was measured with the dolognawmeter, an operant device and assay for measuring functional and mechanical allodynia. Lesions developed on the tongues and esophagi of the 4NQO-treated animals and included hyperkeratoses, papillomas, dysplasias, and cancers. Papillomas included lesions with benign and dysplastic pathological features. Two histologic subtypes of squamous cell carcinomas (SCCs) were identified-SCCs with exophytic and invasive components associated with papillary lesions (pSCCs) and invasive SCCs without exophytic histology (iSCCs). Only the pSCC subtype of tongue cancer was associated with nociceptive behavior. Increased tumor size was associated with greater nociceptive behavior in the mouse model and more pain experienced by oral cancer patients. In addition, depth of invasion was associated with patient-reported pain. The pSCC histology identifies 4NQO-induced tongue cancers that are expected to be enriched for expression and release of nociceptive mediators.

Entities:  

Keywords:  4-nitroquinoline 1-oxide; nociception; nociceptive pain; oral SCC; oral cancer pathology; oral carcinogenesis

Mesh:

Substances:

Year:  2020        PMID: 33030108      PMCID: PMC8173346          DOI: 10.1177/0022034520961020

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  39 in total

Review 1.  Mechanism of cancer pain.

Authors:  Brian L Schmidt; Darryl T Hamamoto; Donald A Simone; George L Wilcox
Journal:  Mol Interv       Date:  2010-06

2.  Development of a New Outcome Prediction Model in Early-stage Squamous Cell Carcinoma of the Oral Cavity Based on Histopathologic Parameters With Multivariate Analysis: The Aditi-Nuzhat Lymph-node Prediction Score (ANLPS) System.

Authors:  Aditi Arora; Nuzhat Husain; Ankur Bansal; Azfar Neyaz; Ritika Jaiswal; Kavitha Jain; Arun Chaturvedi; Nidhi Anand; Kiranpreet Malhotra; Saumya Shukla
Journal:  Am J Surg Pathol       Date:  2017-07       Impact factor: 6.394

3.  Beyond Depth of Invasion: Adverse Pathologic Tumor Features in Early Oral Tongue Squamous Cell Carcinoma.

Authors:  Andrew R Larson; Jacquelyn Kemmer; Eric Formeister; Ivan El-Sayed; Patrick Ha; Jonathan George; William Ryan; Emily Chan; Chase Heaton
Journal:  Laryngoscope       Date:  2019-08-14       Impact factor: 3.325

4.  ERK1/2 regulation of CD44 modulates oral cancer aggressiveness.

Authors:  Nancy P Judd; Ashley E Winkler; Oihana Murillo-Sauca; Joshua J Brotman; Jonathan H Law; James S Lewis; Gavin P Dunn; Jack D Bui; John B Sunwoo; Ravindra Uppaluri
Journal:  Cancer Res       Date:  2011-11-15       Impact factor: 12.701

Review 5.  Profiling early head and neck cancer.

Authors:  Keith D Hunter; E Ken Parkinson; Paul R Harrison
Journal:  Nat Rev Cancer       Date:  2005-02       Impact factor: 60.716

6.  Evaluation of pain in patients with oral squamous cell carcinoma.

Authors:  S Thaddeus Connelly; Brian L Schmidt
Journal:  J Pain       Date:  2004-11       Impact factor: 5.820

Review 7.  Papillary squamous cell carcinoma of the oral mucosa: a clinicopathologic and immunohistochemical study of 12 cases and literature review.

Authors:  Yewei Ding; Liwei Ma; Linjun Shi; Jinqiu Feng; Wei Liu; Zengtong Zhou
Journal:  Ann Diagn Pathol       Date:  2012-06-04       Impact factor: 2.090

8.  Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice.

Authors:  Xiao-Han Tang; Beatrice Knudsen; Debra Bemis; Satish Tickoo; Lorraine J Gudas
Journal:  Clin Cancer Res       Date:  2004-01-01       Impact factor: 12.531

9.  Development of a 4-nitroquinoline-1-oxide model of lymph node metastasis in oral squamous cell carcinoma.

Authors:  Jing Li; Feixin Liang; Dahai Yu; Haiyun Qing; Yiping Yang
Journal:  Oral Oncol       Date:  2012-11-24       Impact factor: 5.337

10.  Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement.

Authors:  S Warnakulasuriya; J Reibel; J Bouquot; E Dabelsteen
Journal:  J Oral Pathol Med       Date:  2008-03       Impact factor: 4.253

View more
  5 in total

1.  A novel rat model of temporomandibular disorder with improved face and construct validities.

Authors:  Anthony Phero; Luiz F Ferrari; Norman E Taylor
Journal:  Life Sci       Date:  2021-10-07       Impact factor: 5.037

2.  Advances in Head and Neck Cancer Pain.

Authors:  Y Ye; D D Jensen; C T Viet; H L Pan; W M Campana; M Amit; M D Boada
Journal:  J Dent Res       Date:  2022-04-13       Impact factor: 8.924

3.  Oral cancer induced TRPV1 sensitization is mediated by PAR2 signaling in primary afferent neurons innervating the cancer microenvironment.

Authors:  Nicole N Scheff; Ian M Wall; Sam Nicholson; Hannah Williams; Elyssa Chen; Nguyen H Tu; John C Dolan; Cheng Z Liu; Malvin N Janal; Nigel W Bunnett; Brian L Schmidt
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.379

4.  Dynamic changes of exhaustion features in T cells during oral carcinogenesis.

Authors:  Wenqiang Xie; Jie Shen; Dikan Wang; Junyi Guo; Qunxing Li; Shuqiong Wen; Wenxiao Dai; Liling Wen; Huanzi Lu; Juan Fang; Zhi Wang
Journal:  Cell Prolif       Date:  2022-02-18       Impact factor: 8.755

5.  The impact of tumor immunogenicity on cancer pain phenotype using syngeneic oral cancer mouse models.

Authors:  Nicole L Horan; Lisa A McIlvried; Megan A Atherton; Mona M Yuan; John C Dolan; Nicole N Scheff
Journal:  Front Pain Res (Lausanne)       Date:  2022-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.